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Background. There is limited evidence on the gene-environmental interaction among 
α-adducin G460W gene polymorphism, sodium intake and blood pressure levels among a 
general population. A priori hypothesis is that the association between G460W polymorphism 
and blood pressure is more evident among persons with higher sodium intake than those with 
lower sodium intake. 
Methods. We conducted a population-based cross-sectional study of 2,823 men and women 
aged 30-74 years in a Japanese rural community to examined the association of the α-adducin 
G460W polymorphism with blood pressure levels stratified by salt intake, as estimated by 
24-hour urine collection and dietary questionnaire.  
Results. There was no difference in systolic or diastolic blood pressure levels among the GG, 
GW and WW groups for women, but for men, mean systolic blood pressure tended to be higher 
in WW group than in the GG group. When we stratified men according to sodium 
excretion/intake, mean systolic blood pressure was significantly higher in the WW group than 
the GG group among men with higher urinary sodium excretion (138.8 vs. 133.6 mmHg, 
p=0.02) and tend to be higher among men with higher past sodium intake. No genetic 
association was found among women or among men with lower urinary sodium excretion or 
lower sodium intake. 
Conclusion. The α-adducin WW genotype was associated with higher systolic blood pressure 
among men with a higher sodium intake.  (223 words) 
Key words: epidemiology, hypertension, sodium, gene-environment interaction, 
salt-sensitivity  
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INTRODUCTION 
α-adducin is a cytoskeletal protein that regulates transmembrane ion transport.1 The genetic 
association of α-adducin polymorphism with salt sensitive hypertension was first reported in 
the Milan Hypertensive Strain rats (MHS)2, and later in Caucasians in Italy and France.3 That 
human study showed not only linkage and association between the α-adducin G460W 
polymorphism (glycine-to-tryptophan substitution) and hypertension, but also a greater 
decrease in mean blood pressure after Weinberger’s salt-sensitivity test or treatment with 
hydrochlorothiazide in GW hypertension patients than in GG patients. Afterward, several 
clinical studies showed a significant relationship between α-adducin polymorphism and 
salt-sensitivity among hypertensive patients.4,5 However, no population-based study was 
performed for gene-environment interaction among α-adducin polymorphism, salt intake, and 
blood pressure.  
 Therefore, we conducted a large community-based observational study of 2,823 
Japanese men and women to carefully examine associations between the α-adducin gene 
polymorphism and blood pressure levels, stratified by sodium intake. Our a priori hypothesis 
is that persons with the 460W allele of α-adducin gene have elevated blood pressure levels in 
response to a higher sodium intake, and thus the association between α-adducin polymorphism 
and blood pressure is more evident among persons with a higher sodium intake than those with 
a lower sodium intake.  
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METHODS 
 
Study population 
The subjects were residents of the rural farming community of Kyowa, central Japan (the 2000 
census population of ages 30-74 years = 9,722). In this community, a general stroke prevention 
program and annual cardiovascular risk survey have been conducted since 1981.6 We included 
in the present study individuals who were aged 30-74 years and participated in the 2001 survey 
(n=2,972). At the time of the survey, physician epidemiologists explained the protocol to all 
participants, and obtained written informed consent from 95% (n=2,823) of them. The data of 
these 2,823 persons were used in the analysis. The study protocol was approved by the Medical 
Ethics Committee of the University of Tsukuba. 
 
Population surveys 
Well-trained blood pressure observers measured arterial systolic blood pressure and fifth-phase 
diastolic blood pressure using standard mercury sphygmomanometers on the right arm of 
quietly seated participants after at least a 5-minute rest. When the first systolic blood pressure 
reading was ≥140 mmHg and/or diastolic blood pressure was ≥90 mmHg, the observers 
repeated the measurement; the average of first and second readings was used in the analyses, 
and otherwise the first reading was used. We used body mass index (BMI) and alcohol intake as 
confounding variables, and urinary sodium excretion estimated by 24-hour urine collection, 
and past and present sodium intake scores estimated by self-administered questionnaire as 
effect modifiers. Height without shoes and weight in light clothing were measured and BMI 
was calculated as weight in kg divided by the square of height in m2. Interviews were 
conducted to determine usual weekly ethanol intake in the go unit, a Japanese traditional unit of 
volume corresponding to 23g ethanol, which was converted to grams of ethanol per day. 
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 All participants in the survey were asked to complete a self-administered questionnaire 
to estimate both present and past habitual sodium intake. Past sodium intake was defined as the 
intake before the recognition of hypertension for hypertensives, and for approximately 10 years 
before the survey for normotensives. A sodium intake score was calculated by adding one point 
for each of 10 types of sodium intake: 1) prefer salty-food, 2) use salty seasoning, 3) eat two or 
more miso soup servings per day, 4) eat pickles two or more times per day, 5) eat salty pickles, 
6) put soy sauce on pickles, 7) put soy sauce on meals, 8) eat salt-preserved food one or more 
times per week, 9) eat salty noodle soup, and 10) do not try to reduce salt intake. This scoring 
system was previously validated7,8, and was tested again in the present study. Sex and 
age-adjusted mean 24-hour sodium excretion values across quintiles of the present sodium 
intake score (n = 1,674) were 168, 180, 183, 195 and 203 mmol/L (p for trend < 0.0001). 
Repeatability of the present and past sodium intake scores was also tested previously7, and was 
tested again by repeating the questionnaire one to two years apart for a sub-sample (n = 287); 
the Spearman correlation coefficient was 0.73 for the present sodium intake score (p<0.0001), 
and 0.62 for the past sodium intake score (p<0.0001). In the present study, 99% of the subjects 
completed the sodium intake questionnaire. 
 To estimate salt intake more accurately, some participants collected one 24-hour urine 
sample. The participants were asked to collect all urine over 24 hours using a 3- or 4-litre 
plastic bottle. They were also asked to record the time of each urination, whether they used 
inappropriate urine collection methods and the number of missed urine collections. For each 
sample, the total urine volume was measured and transferred into 2-ml plastic vials and stored 
at –80°C for a month until analysis. Sodium and potassium concentrations were analyzed using 
an electrolyte analyzer (Hitachi Inflameter 775, Hitachi Ltd., Tokyo, Japan). Urine samples of 
less than 500 ml or those with incomplete collections based on records were excluded from the 
analyses. Urine sodium excretion was calculated by the concentration of each electrolyte 
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(mmol/L) multiplied by the total urine volume (L). We included in the analyses a total of 1,681 
subjects who completed the 24-hour urine collection between 1982 and 2002.  
 
DNA genotyping 
α-Adducin G460W genotypes were determined by allele-specific PCR method using KOD 
DNA polymerase (KODplus; Toyobo, Osaka, Japan), as described elsewhere.9 The designed 
allele-specific sense primers were ACGAAGCTTCCGAGGAXGG for the 460G allele and 
GACGAAGCTTCCGAGGAXTG for the 460W allele, and a 5' biotin-end-labeled antisense 
primer (biotin-CACACCTTAGTCTTCGACTTGG).  
 
Statistical analysis 
The analysis of covariance was used to compare sex-specific age-adjusted mean values of risk 
characteristics according to the genotypes. The chi-square test was used to examine whether 
the genotype distributions differed from that expected from Hardy-Weinberg equilibrium. The 
relationship between genotype and blood pressure levels was examined by the Dunnett’s t test 
stratified by the medians of urinary excretion of sodium, and present and past sodium intake 
scores. We regarded GG genotype as reference for Dunnett’s test. The interactions of genotype 
with age and urinary sodium excretion/intake scores in relation to blood pressure levels were 
examined using cross-product terms. All statistical analyses were performed using SAS 
version 8.02 software (SAS Institute Inc., Cary, NC). All p values for statistical tests were 
two-tailed, and p<0.05 was regarded as statistical significance.  
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RESULTS 
 
The frequencies of α-adducin genotypes were 21.2% (GG), 48.4% (GW), and 30.4% (WW). 
The genotype distribution was in concordance with Hardy-Weinberg equilibrium for men, 
women and total subjects. Table 1 shows sex-specific age-adjusted characteristics of each 
genotype group. None of these characteristics, including antihypertensive medication use, 
varied among the three genotypes. 
 The mean values of blood pressure adjusted for sex, age, antihypertensive medication 
use, BMI, and alcohol consumption among α-adducin genotypes are shown in Table 2. There 
was no difference in blood pressure levels among the GG, GW and WW groups for women, but 
for men, mean systolic blood pressure tended to be higher in WW group than in the GG group. 
This positive association reached statistical significance among older men (≥55 years), and the 
age interaction was also significant (p=0.006). 
When we stratified men by the medians of sodium excretion/intake (Table 3), mean 
systolic blood pressure was 5.2 mmHg higher in the WW group than the GG group in men with 
higher urinary sodium excretion (≥189 mmol/day, mean excretion=257 mmol/day) (p=0.02), 
but not in those with lower excretion (<189 mmol/day, mean excretion=141 mmol/day); the 
interaction was statistically significant (p=0.03). Mean systolic blood pressure was 4.1 mmHg 
higher in the WW group than in the GG group among men with higher past sodium intake 
scores (p=0.08), but not among those with lower scores. However, the interaction did not reach 
statistical significance. The systolic blood pressure did not differ between GG and WW groups 
when stratified by present sodium intake score. Instead, mean systolic blood pressure was 3.1 
mmHg higher in the GW group than in the GG group in subjects with higher present sodium 
intake scores (p=0.08); the interaction did not reach statistical significance. These associations 
became stronger when excluding persons on antihypertensive medication (not shown in the 
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tables). Mean systolic blood pressure in WW groups vs. GG groups were 133.3 vs. 130.3 
mmHg (p=0.09) for men, 137.4 vs. 130.8 mmHg (p=0.01) for men with higher sodium 
excretion, 130.5 vs. 128.1 mmHg (p=0.34) for men with higher present sodium intake score, 
and 134.0 vs. 129.1 mmHg (p=0.06) for men with higher past sodium intake score.  
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DISCUSSION 
 
Among total samples, we found no significant association between the α-adducin G460W 
polymorphism and blood pressure levels in either sex. The lack of a significant association 
between the 460W allele and systolic blood pressure levels overall was not surprising, as this 
finding was consistent with the results of a large group of previous studies.10-23 However, 
among men aged ≥55 years, we found a significant association between the α-adducin G460W 
genotype and systolic blood pressure levels, which was consistent with a recent study of 
Italians.24  
 As we hypothesized a priori, we found a positive association between the α-adducin 
G460W genotype and systolic blood pressure levels among men with higher urinary sodium 
excretion. This finding suggests that the α-adducin genotype may be a genetic risk factor for 
salt-sensitive hypertension. Cusi et al. first showed a positive linkage and association of the 
α-adducin G460W polymorphism with hypertension3: there was also a greater decrease in 
mean arterial pressure after the salt-sensitivity test and chronic diuretic treatment among 
hypertensive patients with the GW genotype compared to those with the GG genotype. 
However, the results of subsequent association studies were inconsistent. Studies in 
African-Americans, who are believed to have a higher prevalence of salt-sensitive 
hypertension, did not show any association between α-adducin G460W polymorphism and 
hypertension.15,16 On the contrary, among people of South African ancestry, the 460W allele 
was more frequent among hypertensives than normotensives.25 Several clinical studies in 
Japan26,27, in Italy4,28,29 and in the United States and France5, but not in Scotland10 or Poland21, 
found relationships of the G460W polymorphism with lower plasma renin activity and/or 
salt-sensitivity. Another recent Japanese community-based study did not show any significant 
association of the α-adducin G460W polymorphism with hypertension or lower plasma renin 
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activity, but they showed that G460W polymorphism was associated with hypertension only 
among younger persons (<60 years) with low plasma renin activity (<1.0 ng/ml per h).22 
 Mean urinary sodium excretion in the present study was 186 mmol/day, which was 
higher than in other studies except one23; 140-164 mmol/day in French and Italian 
hypertensives3, 151 mmol/day in Scottish subjects10, 156 mmol/day in American-Caucasians15, 
168 mmol/day in American-Africans15, 153-172 mmol/day in Italian hypertensives29 and 
165-202 mmol/day in Belgian subjects.23 Moreover, we observed a relationship between the 
460W polymorphism and blood pressure only in the high urinary sodium excretion group 
(mean = 257 mmol/day). This finding was compatible with results from two prior studies4,5. In 
one study of 108 hypertensives4, the increase in mean arterial pressure levels after an acute 
intravenous sodium load (310 mmol over 2 hours) was greater in the GW+WW group than in 
the GG group (+8.1 vs. +2.2 mmHg; p=0.0001) although the baseline mean arterial pressure 
was not different between the two groups. Correspondingly, the urinary sodium excretion after 
the sodium load was lower in the GW+WW group than the GG group (296 vs. 393 μmol/min; 
p<0.03). The other study with 279 hypertensives5 showed that there was a greater systolic 
blood pressure reduction in response to a reduction in dietary sodium intake from high sodium 
balance (24-hour urinary sodium excretion of ≥160 mmol/day) to low sodium balance (≤32 
mmol/day) in WW (-25 mmHg) than GG (-14 mmHg) or GW (-12 mmHg) hypertensive 
patients. Our observations and these experimental findings suggest that the G460W 
polymorphism may be associated with high blood pressure in subjects with a very high sodium 
intake. Inconsistent results from previous observational studies may be partly due to lower 
sodium intakes in their study populations. The present large observational study confirmed the 
genetic association in a general population with a high sodium intake. 
 The strength of the present study was the use of the largest study population of all 
reported studies on α-adducin polymorphisms and the availability of 24-hour urine collections 
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for 60% of the participants and sodium intake scores for all participants. These allowed us to 
test gene-environmental interactions of α-adducin G460W genotypes with blood pressure 
levels in a general population. The present study extended the evidence on the 
gene-environmental interaction, which was suggested by previous clinical studies of 
hypertensives.4,5  
 There were several limitations in the present study. Firstly, if the G460W 
polymorphism largely affects the sodium excretion due to a potential effect on enhanced renal 
sodium reabsorption, the stratification by the sodium excretion may not be adequate because it 
might be influenced by both sodium intake and the genotype itself. However, the 460W allele 
reduces approximately 30% of the sodium excretion only after saline loading4 or high sodium 
diet5, but mean sodium excretion did not vary among the genotypes in free-living 
conditions4,10,15,29,30 including the present study. Thus, the magnitude of effect on urinary 
sodium excretion by the genotype itself may be small in the present study. Secondly, the 
gene-blood pressure associations were not statistically significant when stratified by sodium 
intake scores, although that association among men with higher past sodium intake score 
showed a trend towards significance (p=0.08). The lack of gene-blood pressure association 
among men with higher present sodium intake score was in part due to the under-reporting of 
sodium intake among hypertensives. In this study, the mean present sodium intake score was 
lower among hypertensives than among normotensives (5.4 vs. 5.9, p<0.0001), whereas 
urinary sodium excretion (200.8 vs. 197.3 mmol/day, p=0.56) and past sodium intake score (6.8 
vs. 6.9, p=0.37) did not differ between the two groups. Thirdly, approximately 20% of the 
subjects used antihypertensive medications, which may have obscured the genetic effect of 
blood pressure levels. When we excluded persons on antihypertensive medication from the 
analyses, the association became somewhat stronger for men with higher sodium excretion and 
with higher past sodium intake score. Fourthly, we asked systematically a sample of the 
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participants (about 200 subjects on average) for the urine collection in each annual survey 
between 1982-2002; of these approximately 80% of the subjects agreed to provide urine 
collection samples. When we analyzed the gene-blood pressure association according to years 
between blood pressure measurement and urine collection for men, i.e. <3 years (in 2000-2002: 
29%) and ≥3 years (in 1999 or before: 71%), the results did not differ materially; multivariate 
adjusted mean systolic blood pressure were 133.2mmHg in GG vs. 140.1mmHg in WW for 
men with higher sodium excretion when we used the urine data collected in 2000-2002, 
multivariate adjusted mean systolic blood pressure were 133.7mmHg in GG vs. 137.9mmHg in 
WW for men with higher sodium excretion when we used the urine data collected in 1999 or 
before. There was no interaction between these years and genotype in relation to systolic blood 
pressure levels (p=0.78). Lastly, we did not observe any association between the genotype and 
blood pressure levels among women. A possible reason for the lack of association among 
women is that a lower mean sodium excretion among women than among men (177.0 mmol/d 
vs. 199.0 mmol/d, p<0.0001) may weaken the real association. 
In conclusion, the α-adducin WW genotype was associated with higher systolic blood 
pressure among men with a higher sodium intake estimated by a 24-hour urine collection and 
dietary questionnaire. Our results support the hypothesis that the α-adducin WW genotype is a 
genetic risk factor for salt-sensitive hypertension.  
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Table 1. Age-adjusted characteristics according to alpha-adducin G460W genotype, men and women aged 30-74 years. 
                       
 Women  Men  Total 
            
 GG GW WW  GG GW WW  GG GW WW 
                       
Number 362  860  553   237  505  306   599  1,365  859  
Age, year 57.0  56.5  56.8   59.2  58.5  59.6   57.9  57.3  57.8  
Systolic blood pressure, mmHg 131.7  131.3  129.7   133.3  134.9  135.1   132.3  132.7  131.6  
Diastolic blood pressure, mmHg 77.3  77.1  76.5   80.9  80.7  81.0   78.7  78.5  78.1  
Use of antihypertensive medication, % 21.9  20.4  23.0   25.0  23.7  21.6   23.1  21.6  22.5  
Hypertension, %† 40.6  38.1  36.8   47.8  47.4  47.5   43.3  41.6  40.6  
Body mass index, kg/m2 23.7  23.5  23.4   24.0  23.9  23.8   23.8  23.6  23.5  
Alcohol intake, g/day 2.0  1.6  1.3   20.8  21.4  20.7   9.4  9.0  8.2  
             
24h urine collection (n) 193  494  318   165  320  191   358  814  509  
Urine sodium excretion (mmol) 173.1  177.4  178.8   199.3  196.3  203.1   185.3  185.0  187.7  
              
Present sodium questionnaire completed (n) 361  854  549   235  500  303   596  1,354  852  
Present sodium intake score 4.6  4.6  4.7   5.9  5.7  5.5   5.1  5.0  5.0  
Past sodium questionnaire completed (n) 359  854  548   233  496  302   592  1,350  850  
Past sodium intake score 5.8  5.9  6.0   7.0  6.8  6.7   6.2  6.3  6.2  
                       
†Hypertension was defined as systolic blood pressure of ≥ 140 mmHg and/or diastolic blood pressure, of ≥ 90 mmHg and/or use of antihypertensive 
medication.  
 
Table 2. Blood pressure levels according to alpha-adducin G460W genotype, men and women 
aged 30-74 years. 
           
      
 GG GW WW p for difference of GG vs WW 
           
Men 237  505  306   
  Systolic blood pressure, mmHg 133.1  134.8  135.4  0.14  
  Diastolic blood pressure, mmHg 80.8  80.7  81.2  0.89  
      
Women 362  860  553   
  Systolic blood pressure, mmHg 131.4  131.4  129.8  0.15  
  Diastolic blood pressure, mmHg 77.1  77.1  76.6  0.60  
      
Total 599  1,365  859   
  Systolic blood pressure, mmHg 132.0  132.7  131.8  0.95  
  Diastolic blood pressure, mmHg 78.5  78.5  78.3  0.87  
      
Men ages <55 years 80  176  90   
  Systolic blood pressure, mmHg 131.1  127.9  129.6  0.68  
  Diastolic blood pressure, mmHg 83.3  80.5  82.5  0.82  
      
Men ages ≥55 years 157  329  216   
  Systolic blood pressure, mmHg 134.0  138.3  138.2  0.02  
  Diastolic blood pressure, mmHg 79.4  80.9  80.6  0.38  
      
           
Blood pressures were adjusted for sex, age, antihypertensive medication use, body mass index and 
alcohol consumption. 
Tests for difference from GG genotype were conducted using Dunnett's multiple comparison 
method. 
 
Table 3. Blood pressure levels according to alpha-adducin G460W genotype, stratified 
by sodium excretion/intake, men aged 30-74 years.  
            
 Men 
       
 GG GW WW  p for difference of GG vs WW
            
Stratified by urinary sodium excretion       
<189.4 mmol/day 85  161  92    
  Systolic blood pressure, mmHg 133.9  137.9 134.2   0.99  
  Diastolic blood pressure, mmHg 79.9  81.5  81.3   0.51  
≥189.4 mmol/day 80  159  99    
  Systolic blood pressure, mmHg 133.6  134.6 138.8   0.02  
  Diastolic blood pressure, mmHg 79.9  80.5  81.5   0.41  
       
Stratified by present sodium intake score       
<6 97  208  144    
  Systolic blood pressure, mmHg 136.1  136.3 138.6   0.31  
  Diastolic blood pressure, mmHg 81.8  82.0  82.2   0.91  
≥6 138  292  159    
  Systolic blood pressure, mmHg 130.7  133.8 132.3   0.53  
  Diastolic blood pressure, mmHg 79.9  79.9  80.3   0.93  
       
Stratified by past sodium intake score       
<8 135  304  191    
  Systolic blood pressure, mmHg 132.9  134.9 134.8   0.42  
  Diastolic blood pressure, mmHg 80.3  80.9  82.0   0.20  
≥8 98  192  111    
  Systolic blood pressure, mmHg 132.2  135.0 136.3   0.08  
  Diastolic blood pressure, mmHg 80.9  80.6  79.8   0.59  
       
            
Blood pressures were adjusted for sex, age, antihypertensive medication use, body mass 
index and alcohol consumption. 
Tests for difference from GG genotype were conducted using Dunnett's multiple 
comparison method. 
 
